Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Canadian Anaesthetists' Society Journal|March 1, 1986
Prolonged neuromuscular blockade with atracuriumM D Bizzarri-Schmid, S P Desai
Hepato-Gastroenterology|February 1, 1980
Effects of antigastrin drugs on the interaction of 125I-human gastrin with rat gastric mucosa membranesR R Vidal y Plana, A Cifarelli, D Bizzarri
Arzneimittel-Forschung|January 1, 1979
Studies on the safety of a new non-steroidal anti-inflammatory drug: protacine (CR 604)R R Vidal y Plana, A Cifarelli, D Bizzarri, et al.
Bioinformatics (Oxford, England)|June 13, 2022
MiMIR: R-shiny application to infer risk factors and endpoints from Nightingale Health's 1H-NMR metabolomics dataD Bizzarri, M J T Reinders, M Beekman, et al.
Arzneimittel-Forschung|January 1, 1979
Studies on the mechanism of action of protacine (CR 604), a new non-steroidal anti-inflammatory agentR R Vidal y Plana, F Makovec, A Cifarelli, et al.
Arzneimittel-Forschung|January 1, 1979
Pharmacological study of a new non-steroidal anti-inflammatory drug: protacine (CR 604)A L Rovati, R R Vidal y Plana, P L Casula, et al.
Ebiomedicine|December 23, 2021
1H-NMR metabolomics-based surrogates to impute common clinical risk factors and endpointsD Bizzarri, M J T Reinders, M Beekman, et al.
Pageof 1